ACTU Actuate Therapeutics, Inc: Bozor kapitallashuvining balans qiymatiga nisbati
Actuate Therapeutics, Inc. (ACTU) og'ir o'smalarga qarshi kurashish uchun GSK-3 protein inhibitorlarini ishlab chiqish orqali zamonaviy terapevtik muhitni yaratmoqda. Joriy tadqiqot va ishlanmalar (R&D) liniyasi belgilangan jadvalga muvofiq faol klinik tasdiqlash bosqichidan o'tmoqda. 9.10 metriki bilan aks etgan aksiya narxlari tarixi aktivning dinamikasini aniq ko'rsatadi. Shuningdek, kompaniya biomarkerlarni avtomatlashtirilgan tahlili uchun bulutli robototexnikani joriy qilmoqda, bu esa tibbiy sinovlarning o'tkazilishini sezilarli darajada tezlashtiradi.
%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261030&filename=GURU_Markets_-_ACTU_-_Actuate-Therapeutics-Inc._-_Market-Cap-to-Net-Assets-Ratio "Actuate Therapeutics, Inc (ACTU) Bozor kapitallashuvining balans qiymatiga nisbati: 14.08.2024 - 30.10.2026 davri uchun | 👁️GURU.Markets👁️")
Actuate Therapeutics Inc. (ACTU) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Actuate Therapeutics, Inc.|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Actuate Therapeutics, Inc|ACTU - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Actuate Therapeutics, Inc|ACTU - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Actuate Therapeutics|Tezkor likvidlik koeffitsiyenti actuatetherapeutics.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. (ACTU) rahbariyati ichki jarayonlarni ochiq bozor standartlariga moslashtirayotgan va klinik bosqichlarga e'tibor qaratayotgan bir paytda, investorlar kapital samaradorligini kuzatib borishlari kerak. Ushbu ko'rsatkich kompaniyaning bozor qiymatini uning sof aktivlariga solishtirib, biznesning balans qiymatiga nisbatan haddan tashqari qimmat yoki arzon baholanganligini aniqlaydi. Market-to-book koeffitsiyentidagi o'zgarishlarni tahlil qilish orqali investorlar aksiyadorlar qiymatining yo'qolish xavfini real vaqt rejimida aniqlashlari mumkin.
Actuate Therapeutics, Inc. kimlar bilan raqobatlashadi
ONC (BeiGene Ltd) - Kapitallashuvning sof aktivlarga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|CTOR (Citius Oncology Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati HURA (TuHURA Biosciences)|TARA - Kapitallashuvning sof aktivlarga nisbati|FATE: Kapitallashuvning sof aktivlarga nisbati|WHWK - Bozor kapitallashuvining balans qiymatiga nisbati|tscan.com (TCRX) - Bozor qiymatining balans qiymatiga nisbati|Champions Oncology, Inc. - Balans qiymatiga nisbatan bozor qiymati|XBIT (XBiotech Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp CVM|Bozor kapitallashuvining balans qiymatiga nisbati OSTX|Bozor kapitallashuvining balans qiymatiga nisbati Radiopharm Theranostics Ltd (RADX)|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|ANL - Kapitallashuvning sof aktivlarga nisbati|VERU: Kapitallashuvning sof aktivlarga nisbati|Tempest Therapeutics Corp - Bozor kapitallashuvining balans qiymatiga multiplikatori|XLO (xiliotx.com) - Kapitallashuvning sof aktivlarga nisbati|Renovaro (RENB) - Bozor kapitallashuvining balans qiymatiga nisbati|MURA (Mural Oncology PLC) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Kairos Pharma Inc|Kapitallashuvning sof aktivlarga nisbati OKUR (OnKure Therapeutics Inc)|Bozor kapitallashuvining balans qiymatiga multiplikatori GDTC|Bozor kapitallashuvining balans qiymatiga nisbati CRIS (Curis)|Apollomics Inc. (APLM) - Bozor qiymatining balans qiymatiga koeffitsiyenti|THAR: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ADVB (Advanced Biomed Inc)|GNPX (Genprex, Inc) - Kapitallashuvning sof aktivlarga nisbati|CLDI: Bozor kapitallashuvining balans qiymatiga multiplikatori|SBFM (Sunshine Biopharma) - Bozor kapitallashuvining balans qiymatiga nisbati|XBIO: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SLRX|PPBT - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc. AONC|Balans qiymatiga nisbatan bozor qiymati BGNE|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ELEV - Bozor kapitallashuvining balans qiymatiga nisbati|icadmed.com (ICAD) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi IKNA (Ikena Oncology)|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Viracta VIRX|Kapitallashuvning sof aktivlarga nisbati MOR (MorphoSys AG)|Bozor kapitallashuvining balans qiymatiga nisbati nayabiosciences.com (NAYA)|Ascentage Pharma - Kapitallashuvning sof aktivlarga nisbati